111 related articles for article (PubMed ID: 15011408)
1. [Drug induced dementia--anti-parkinsonian drugs].
Naito Y; Kuzuhara S
Nihon Rinsho; 2004 Jan; 62 Suppl():470-4. PubMed ID: 15011408
[No Abstract] [Full Text] [Related]
2. [Toxic and adverse neurological effects of anti-parkinsonian drugs].
Sunohara N
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715
[No Abstract] [Full Text] [Related]
3. Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA; Fox SH; Crossman AR; Brotchie JM
Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
[No Abstract] [Full Text] [Related]
4. Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications.
Kis B; Hedrich K; Kann M; Schwinger E; Kömpf D; Klein C; Pramstaller PP
Neurology; 2005 Sep; 65(5):761. PubMed ID: 16157916
[No Abstract] [Full Text] [Related]
5. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
Bezard E; Brotchie JM; Gross CE
Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
Young BK; Camicioli R; Ganzini L
Drugs Aging; 1997 May; 10(5):367-83. PubMed ID: 9143857
[TBL] [Abstract][Full Text] [Related]
7. [Understanding and treating levodopa-induced dyskinesias].
Hadj Tahar A; Bédard PJ
Tunis Med; 1998 Dec; 76(12):437-47. PubMed ID: 10093483
[No Abstract] [Full Text] [Related]
8. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Greene P; Cote L; Fahn S
Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
[No Abstract] [Full Text] [Related]
9. L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
Cenci MA
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S263-7. PubMed ID: 18267248
[TBL] [Abstract][Full Text] [Related]
10. [Hallucinations in Parkinson's disease].
Moser A; Hagenah J; Kömpf D
Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
[TBL] [Abstract][Full Text] [Related]
11. [Possibilities for neurotransmitter correction in parkinsonism (a review)].
Man'kovskiĭ NB; Karaban' IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1404-11. PubMed ID: 2892328
[No Abstract] [Full Text] [Related]
12. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.
Perry EK; Perry RH
Brain Cogn; 1995 Aug; 28(3):240-58. PubMed ID: 8546852
[TBL] [Abstract][Full Text] [Related]
13. Ropinirole as compared with levodopa in Parkinson's disease.
Yamamoto T
N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001685
[No Abstract] [Full Text] [Related]
14. Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
Rascol O; Brefel-Courbon C; Descombes S; Montastruc JL
Adv Neurol; 1999; 80():485-90. PubMed ID: 10410760
[No Abstract] [Full Text] [Related]
15. Drug-induced confusional states: the usual suspects?
Hufschmidt A; Shabarin V; Zimmer T
Acta Neurol Scand; 2009 Dec; 120(6):436-8. PubMed ID: 19804475
[TBL] [Abstract][Full Text] [Related]
16. [Medicinal treatment of idiopathic Parkinson's disease].
Klockgether T
Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
[TBL] [Abstract][Full Text] [Related]
17. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
Ludin HP
Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654
[TBL] [Abstract][Full Text] [Related]
18. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
Encarnacion EV; Hauser RA
Eur Neurol; 2008; 60(2):57-66. PubMed ID: 18480609
[TBL] [Abstract][Full Text] [Related]
19. [Physiopathology of parkinsonism and dyskinesias: lessons from surgical observations]].
Linazasoro G
Neurologia; 2001 Jan; 16(1):17-29. PubMed ID: 11234658
[TBL] [Abstract][Full Text] [Related]
20. Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
Johnston TH; van der Meij A; Brotchie JM; Fox SH
Mov Disord; 2010 Jul; 25(10):1379-90. PubMed ID: 20310030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
